Sharon Boast
- Molecular Biology top 10%
- Immunology top 5%
- Hematology top 1%
- Genetics top 10%
- Oncology top 10%
- Co-authors
- Stephen P. GoffJeff HardinIhor R. LemischkaFrancesco BlasiPasquale VerdePamela L. SchwartzbergAlan M. StallClaudio D. Stern
- Topics
- Chronic Myeloid Leukemia Treatments (7 papers)CRISPR and Genetic Engineering (4 papers)Animal Genetics and Reproduction (4 papers)
- Cited by
- HematologyImmunologyGenetics
- Partner nations
- United StatesUnited KingdomSingapore
In The Last Decade
Sharon Boast
25 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 1.2k
- Immunology 705
- Hematology 691
- Genetics 327
- Oncology 309
Countries citing papers authored by Sharon Boast
This map shows the geographic impact of Sharon Boast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Boast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Boast more than expected).
Fields of papers citing papers by Sharon Boast
This network shows the impact of papers produced by Sharon Boast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Boast. The network helps show where Sharon Boast may publish in the future.
Co-authorship network of co-authors of Sharon Boast
This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Boast. A scholar is included among the top collaborators of Sharon Boast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Boast. Sharon Boast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | 44 | |
| 3 | 50 | |
| 4 | 10 | |
| 5 | 144 | |
| 6 | 92 | |
| 7 | 124 | |
| 8 | 414 | |
| 9 | 33 | |
| 10 | Transgenes encoding both type I and type IV c-abl proteins rescue the lethality of c-abl mutant mice. | 16 |
| 11 | 455 | |
| 12 | 35 | |
| 13 | 12 | |
| 14 | 290 | |
| 15 | 10 | |
| 16 | 117 | |
| 17 | 4 | |
| 18 | 99 | |
| 19 | 181 | |
| 20 | 19 |
About Sharon Boast
Sharon Boast is a scholar working on Hematology, Genetics and Immunology and Allergy, having authored 25 papers that have together received 2.4k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (7 papers), CRISPR and Genetic Engineering (4 papers) and Animal Genetics and Reproduction (4 papers). The work is most often cited by research in Hematology (691 citations), Immunology (705 citations) and Genetics (302 citations). Sharon Boast has collaborated with scholars based in United States, United Kingdom and Singapore. Frequent co-authors include Stephen P. Goff, Jeff Hardin, Ihor R. Lemischka, Francesco Blasi, Pasquale Verde, Pamela L. Schwartzberg, Alan M. Stall, Claudio D. Stern, H. Shelton Earp and Margaret L. Harbison. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.